Insider · CIK 0001908044
Marissa Brittenham
officer
Files at SGRY (Surgery Partners, Inc.). First filing Feb 10, 2025, latest Mar 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $452k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SGRY: Surgery Partners, Inc.
SGRYOct 9, 2026 · close 13.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Surgery Partners, Inc. | $76k 3,156 shares | -5% | - | |
| 51Moderate | Surgery Partners, Inc. | $376k 14,700 shares | -23% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | SGRY Surgery Partners, Inc. | SOpen-market sale Common Stock | -3,156 | $24.09 | $76k | 63,408 | Mar 13, 2025 |
| Mar 4, 2025 | SGRY Surgery Partners, Inc. | AGrant or award Common Stock | +10,084 | $23.80 | $240k | 60,262 | Mar 6, 2025 |
| Mar 4, 2025 | SGRY Surgery Partners, Inc. | AGrant or award Common Stock | +6,302 | $23.80 | $150k | 66,564 | Mar 6, 2025 |
| Feb 7, 2025 | SGRY Surgery Partners, Inc. | SOpen-market sale Common Stock | -14,700 | $25.61 | $376k | 50,178 | Feb 10, 2025 |
| Jan 31, 2025 | SGRY Surgery Partners, Inc. | AGrant or award Common Stock | +25,110 | $0.00 | $0 | 64,878 | Feb 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.